PPARGC1A and hepatocellular carcinoma: Notably, PPARGC1A was up-regulated in our DEN-induced rat HCC model, whereas several large-scale human studies have documented a marked down-regulation of PPARGC1A in hepatocellular carcinoma and linked its low expression to poor prognosis [32].